Novartis AG
Glycoside derivatives and uses thereof
Last updated:
Abstract:
This invention relates to compounds represented by formula (I): ##STR00001## wherein the variables are defined as herein above, which are useful for treating diseases and conditions mediated by the sodium D-glucose co-transporter (SGLT), e.g. diabetes. The invention also provides methods of treating such diseases and conditions, and compositions etc. for their treatment.
Status:
Grant
Type:
Utility
Filling date:
18 Feb 2020
Issue date:
24 May 2022